OpenAlex
PricingAboutJobs
Log inGet started
Work

Phase II/III randomized trial of TCH346 in patients with ALS

HTML

Year: 2007
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Neurology
DOI: 10.1212/01.wnl.0000269676.07319.09
Authors: R. Miller, W. Bradley, M. Cudkowicz, J. Hubble, V. Meininger, H. Mitsumoto, D. Moore, H. Pohlmann, D. Sauer, V. Silani, M. Strong, M. Swash, E. Vernotica, The TCH346 Study Group
Institutions: California Pacific Medical Center, University of Miami, Pitié-Salpêtrière Hospital, Columbia University, Novartis (Switzerland), University of Milan
Language: Dutch

Topic: Amyotrophic Lateral Sclerosis Research
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: amyotrophic lateral sclerosis, glyceraldehyde-3-phosphate dehydrogenase, apoptosis, anti-apoptotic therapy, disease progression, survival, lung function, manual muscle strength
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2025813837
FWCI: 6.511
Cites: 26
Cited by: 132
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security